Ultima-HGH Fragment 176-191, 10 mg

Ultima-HGH Fragment 176-191 10 mg contains HGH Fragment 176-191, a synthetic peptide corresponding to the C-terminal portion of human growth hormone. It is primarily researched for lipolysis, fat metabolism, adipose-tissue signaling, and body-composition pathways.

How it works

HGH Fragment 176-191 represents amino acids 176 through 191 of human growth hormone. Research has focused on whether this region can reproduce some of GH’s lipolytic and anti-lipogenic activity without activating the classical growth-promoting GH pathway.

Proper Use and Dosage

The listed presentation contains 10 mg (10,000 mcg) per vial.

For the 10 mg presentation:

• 100 mcg = 100 portions
• 250 mcg = 40 portions
• 500 mcg = 20 portions
• 1 mg = 10 portions
• 2 mg = 5 portions
• 2.5 mg = 4 portions
• 5 mg = 2 portions
• 10 mg = 1 full vial

Benefits

Ultima-HGH Fragment 176-191 is particularly relevant to research involving fat metabolism, lipolysis, body composition, and adipose-tissue biology.

Key areas of interest include:

• Investigated for lipolysis
• Supports research into fat oxidation
• Studied for inhibition of lipogenesis
• Relevant to adipose-tissue signaling
• Investigated for body-composition pathways
• Studied in relation to visceral and abdominal fat
• Does not represent full-length HGH
• Research interest in metabolic pathways without classical GH signaling
• Particularly relevant to fat-loss-focused research
• Convenient 10 mg presentation

The compound’s main research appeal is its proposed ability to influence fat metabolism without reproducing the complete biological activity of full-length growth hormone. Most evidence supporting these effects remains preclinical.

Side Effects

Because unmodified HGH Fragment 176-191 lacks controlled human clinical studies, its human safety and side-effect profile have not been adequately established. This is an important distinction from AOD-9604, a modified relative that underwent human clinical development.